GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Genetic Mutations in ESKs and GAD3 Genes Found to Enhance Tomato Sugar Content and GABA Levels

by GOAI
Share To

Researchers have identified genetic mutations in tomatoes that can enhance fruit quality by increasing sugar content and gamma-aminobutyric acid (GABA) accumulation. The study focused on the effects of mutations in two specific genes, ESKs and GAD3, which play a role in regulating these traits. The findings suggest that targeted modifications to these genes could potentially improve the nutritional profile and taste of tomatoes.

The research team analyzed how alterations in ESKs and GAD3 genes influenced tomato metabolism. They observed that mutations in ESKs were associated with higher sugar levels, while changes to GAD3 resulted in increased GABA accumulation. Both sugar content and GABA are important factors for consumer preference and health benefits, as sugars contribute to sweetness, and GABA is linked to potential stress-relieving properties. The study provides detailed insights into the genetic mechanisms underlying these changes, offering valuable information for future agricultural applications aimed at improving crop quality.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top